CAMELI, MATTEO
 Distribuzione geografica
Continente #
NA - Nord America 3.759
AS - Asia 2.126
EU - Europa 1.626
SA - Sud America 515
AF - Africa 74
Continente sconosciuto - Info sul continente non disponibili 48
OC - Oceania 8
Totale 8.156
Nazione #
US - Stati Uniti d'America 3.491
SG - Singapore 724
CN - Cina 548
RU - Federazione Russa 527
IT - Italia 489
BR - Brasile 387
VN - Vietnam 310
BD - Bangladesh 188
GB - Regno Unito 130
CA - Canada 127
HK - Hong Kong 120
DE - Germania 95
FR - Francia 73
SE - Svezia 67
IN - India 62
FI - Finlandia 52
MX - Messico 50
AR - Argentina 48
PL - Polonia 36
NL - Olanda 35
ID - Indonesia 32
ZA - Sudafrica 31
TR - Turchia 27
UA - Ucraina 26
EC - Ecuador 22
ES - Italia 21
JP - Giappone 20
CO - Colombia 18
AT - Austria 17
CR - Costa Rica 14
LT - Lituania 14
TT - Trinidad e Tobago 14
IE - Irlanda 13
IQ - Iraq 13
PK - Pakistan 13
CL - Cile 12
HN - Honduras 12
IL - Israele 12
MA - Marocco 12
VE - Venezuela 12
PR - Porto Rico 11
SV - El Salvador 11
GT - Guatemala 9
TN - Tunisia 9
AE - Emirati Arabi Uniti 7
CW - ???statistics.table.value.countryCode.CW??? 7
JM - Giamaica 7
MY - Malesia 7
SA - Arabia Saudita 7
UZ - Uzbekistan 7
EG - Egitto 6
KE - Kenya 6
AU - Australia 5
BO - Bolivia 5
PH - Filippine 5
HU - Ungheria 4
NI - Nicaragua 4
UY - Uruguay 4
AL - Albania 3
AM - Armenia 3
AZ - Azerbaigian 3
DZ - Algeria 3
GP - Guadalupe 3
GR - Grecia 3
OM - Oman 3
PE - Perù 3
PY - Paraguay 3
SI - Slovenia 3
BE - Belgio 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
KG - Kirghizistan 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PA - Panama 2
PT - Portogallo 2
QA - Qatar 2
RO - Romania 2
RS - Serbia 2
TW - Taiwan 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BW - Botswana 1
CG - Congo 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
GG - Guernsey 1
JO - Giordania 1
KR - Corea 1
KW - Kuwait 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
NG - Nigeria 1
Totale 8.109
Città #
Dallas 1.125
Singapore 367
San Jose 342
Ashburn 299
Beijing 198
Council Bluffs 180
Los Angeles 124
Hong Kong 118
Moscow 105
Ho Chi Minh City 103
New York 101
Hanoi 76
Santa Clara 73
Milan 65
Chandler 62
Phoenix 56
Rome 51
São Paulo 50
Orem 39
Lauterbourg 38
Montreal 38
The Dalles 35
Buffalo 32
Munich 32
Helsinki 30
Warsaw 30
Hefei 29
Boardman 28
Denver 26
London 26
San Mateo 26
Mexico City 25
Johannesburg 24
Frankfurt am Main 23
Ottawa 23
Seattle 22
Amsterdam 21
Fairfield 20
Naples 20
Pisa 19
Tokyo 19
Chennai 18
Chicago 18
Brooklyn 17
Florence 17
Stockholm 17
Beauharnois 16
Cambridge 16
Houston 16
Atlanta 15
Bologna 14
New Delhi 14
Poplar 14
Toronto 14
Turin 14
Washington 14
Dublin 13
Figino 13
Rio de Janeiro 13
Da Nang 12
Manchester 12
Boston 11
Nuremberg 11
Paris 11
Portsmouth 11
Querétaro 11
Turku 11
Assago 10
Istanbul 10
Lawrence 10
San José 10
Stevenage 10
Woodbridge 10
Ankara 9
Columbus 9
Dong Ket 9
Lappeenranta 9
Mumbai 9
Quito 9
San Francisco 9
San Salvador 9
Shanghai 9
Charlotte 8
Guayaquil 8
Leeds 8
Medellín 8
Port of Spain 8
Suzhou 8
Tel Aviv 8
Thái Bình 8
Wilmington 8
Brasília 7
Haiphong 7
Jacksonville 7
Palermo 7
Philadelphia 7
Salt Lake City 7
Vancouver 7
Verona 7
Vienna 7
Totale 4.759
Nome #
High prevalence of wild-type transthyretin cardiac amyloidosis in older adults with carpal tunnel syndrome, heart failure or increased left ventricular mass: The CAPTURE study 754
Eligibility for vericiguat in a real‐world, contemporary heart failure population 324
[Rationale and significance of the Italian Network for Cardiac Amyloidosis] 316
Approach to the diagnosis and management of patients with cardiac amyloidosis. A consensus document by the Tuscan section of the Italian Association of Hospital Cardiologists (ANMCO) and the Tusco-Umbrian section of the Italian Society of Cardiology (SIC) 303
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study 301
Stress echo 2030: The novel ABCDE-(FGLPR) protocol to define the future of imaging 291
Haemodynamic forces predicting remodelling and outcome in patients with heart failure treated with sacubitril/valsartan 276
Sacubitril/valsartan reduces indications for arrhythmic primary prevention in heart failure with reduced ejection fraction: insights from DISCOVER-ARNI, a multicenter Italian register 268
Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis 262
Early diagnosis, disease stage and prognosis in wild-type transthyretin amyloid cardiomyopathy: The DIAMOND study 258
Perspectives in noninvasive imaging for chronic coronary syndromes 251
Early diagnosis, disease stage and prognosis in wild‐type transthyretin amyloid cardiomyopathy: The DIAMOND study 250
Deformation Imaging by Strain in Chronic Heart Failure Over Sacubitril-Valsartan: A Multicenter Echocardiographic Registry 248
Diagnostic pathways to wild-type transthyretin amyloid cardiomyopathy: a multicentre network study 240
Diagnosis and management of patients with left ventricular hypertrophy: Role of multimodality cardiac imaging. A scientific statement of the Heart Failure Association of the European Society of Cardiology 234
Characteristics of patients with suspected cardiac amyloidosis in Tuscany and Umbria: Insights from the cardiac amyloidosis RegistRY (CARRY) 231
Right ventricular strain predicts outcome in patients receiving sacubitril/valsartan: A sub-analysis of DISCOVER-ARNI 226
null 226
Myocardial 123I-metaiodobenzylguanidine imaging in hypertension and left ventricular hypertrophy 221
Arterial hypertension and atrial fibrillation: Standard and advanced echocardiography from diagnosis to prognostication 221
null 218
The importance of integrated left atrial evaluation: From hypertension to heart failure with preserved ejection fraction 218
Sex-related differences in ventricular remodeling after myocardial infarction 216
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide survey 210
Myocarditis and pericarditis during COVID-19 pandemic: a study of the Italian Society of Cardiology 207
The diseased Tricuspid valve. Non invasive imaging of Tricuspid valve – Ultrasounds Trans-Thoracic Echocardiography (TTE) and Trans-Esophageal Echocardiography (TTE). 202
The analysis of left atrial function predicts the severity of functional impairment in chronic heart failure: The FLASH multicenter study 198
Resistant hypertension: An overview 188
Speckle tracking echocardiography in heart failure development and progression in patients with apneas 180
The role of non-invasive imaging modalities in cardiac allograft vasculopathy: an updated focus on current evidences 120
Contemporary medical therapy for heart failure across the ejection fraction spectrum: The OPTIPHARM-HF registry 117
Real-world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population 91
OPTImal PHARMacological therapy for patients with heart failure: Rationale and design of the OPTIPHARM-HF registry 90
ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC-TIVE study 71
High Prevalence of Wild-Type Transthyretin Cardiac Amyloidosis in Older Adults with Carpal Tunnel Syndrome, Heart Failure or Increased Left Ventricular Mass: The CAPTURE Study 37
Epidemiological and clinical boundaries of heart failure with preserved ejection fraction 34
Cardiogenic shock and acute kidney injury: the rule rather than the exception 30
Evaluation of left intraventricular flow dynamics using the novel non-contrast HyperDoppler technique 28
Totale 8.156
Categoria #
all - tutte 39.069
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.069


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022105 0 0 0 7 2 8 11 27 8 22 9 11
2022/2023140 11 28 3 22 12 17 2 10 17 5 10 3
2023/2024209 11 3 29 11 10 26 19 4 7 16 9 64
2024/20251.308 27 27 99 26 76 72 194 306 113 50 187 131
2025/20265.410 229 652 1.111 630 538 331 433 256 328 301 352 249
2026/2027864 111 136 321 296 0 0 0 0 0 0 0 0
Totale 8.156